¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï´ëÇб³º´¿ø SNUH Update symposium : 2021-12-11

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼­¿ï´ëÇб³º´¿ø SNUH Update symposium : 2021-12-11
±³À°ÀÏÀÚ : 2021-12-11
±³À°Àå¼Ò : ¿Â-¿ÀÇÁ¶óÀÎ ±³À° (¸óµå¸®¾È ¼­¿ï ÀÌÅ¿ø ±×·£µåº¼·ë1)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ,¿ÀÇÁ¶óÀÎ º´Çà) SNUH Update symposium
ÁÖÃÖ±â°ü : ¼­¿ï´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ÈäºÎ¿Ü°ú  
´ã´çÀÚ : ¼Ò¶ó
¿¬¶ôó : 02-2072-2347  
À̸ÞÀÏ : srsr@snuh.org      
±³À°Á¾·ù : ÈäºÎ¿Ü°ú      
Âü¼®¿¹»óÀοø : 120¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 21ºÐ  
¼¼ºÎ¼ö°­·á : 20,000¿ø      
ºñ°í Àü¹®ÀÇ 2¸¸¿ø / Àü°øÀÇ,°£È£»ç, ±âŸ 1¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 08:30~08:45 The importance of cardiac rehabilitation and fitness in patients with congenital heart disease  Naomi Gauthier(Harvard medical school Boston Children) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 08:45~09:00 Methods to evaluate, collect and measure results of our efforts to patients  Naomi Gauthier(Harvard medical school Boston Children) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 09:00~09:12 Our practice (Boston Children¡¯s Hospital) and program in detail  Tracy Curran(Boston Children) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 09:12~09:24 Unexpected events during cardiac fitness program: How to deal with these situations?  Tracy Curran(Boston Children) 
Åä·Ð 12-11 ±×·£µåº¼·ë1 09:24~09:39 discussion  1.¹Úõ¼ö 2.¼Û¹Ì°æ(1.¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø ÈäºÎ¿Ü°ú 2.¼­¿ïÀÇ´ë ¼­¿ï´ëº´¿ø ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú) 
È޽Ġ12-11 ±×·£µåº¼·ë1 09:39~09:44 È޽Ġ () 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 09:44~09:56 Interpretation of CPET and application in real world  ÀÌ»óÀ±(¼­¿ïÀÇ´ë ¼­¿ï´ëº´¿ø ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³â°ú) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 09:56~10:08 Exercercise recommendation for congenital heart diseases  ÀÌÀ¯Çü(¼­¿ïÀÇ´ë ¼­¿ï´ë¾î¸°À̺´¿ø ¼Ò¾ÆÀçÈ°ÀÇÇаú) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 10:08~10:20 Practices in Seoul  ±èÇöÁ¤(¼­¿ï½Ã¸³´ë ½ºÆ÷Ã÷°úÇаú) 
Åä·Ð 12-11 ±×·£µåº¼·ë1 10:20~10:35 Discussion  1.±è¼öÁø 2.¹ÚÇѱâ(1.ºÎõ¼¼Á¾º´¿ø ¼Ò¾Æû¼Ò³â°ú 2.¿¬¼¼ÀÇ´ë ½ÅÃ̼¼ºê¶õ½ºº´¿ø ÈäºÎ¿Ü°ú) 
È޽Ġ12-11 ±×·£µåº¼·ë1 10:35~10:40 È޽Ġ () 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 10:40~10:52 Nutritional recommendation in single ventricle patients  ±èÁö¿µ(¼­¿ï´ëº´¿ø ¾î¸°À̺´¿ø ¿µ¾ç°ú) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 10:52~11:04 Psychological management and support for congenital caridac diseases in postoperative period  ÀÌÁ¤(¼­¿ïÀÇ´ë ¼­¿ï´ë¾î¸°À̺´¿ø Á¤½Å°Ç°­ÀÇÇаú) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 11:04~11:16 Quality of life after congenital caridac surgery  ÇãÁ¾È£(¼­¿ïÀÇ´ë ÀÌÁ¾¿í ±Û·Î¹ú ¼¾ÅÍ º¸°ÇÇÐ ÀÚ¹®À§¿ø ±¹È¸ ¹Ì·¡ ¿¬±¸¿ø) 
Åä·Ð 12-11 ±×·£µåº¼·ë1 11:16~11:31 Discussion  1.¼ÛÁø¿µ 2.±èÇüÅÂ(1.¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø ¼Ò¾Æû¼Ò³â°ú 2.ºÎ»êÀÇ´ë ¾ç»êºÎ»ê´ëº´¿ø ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 12:00~12:30 Special lecture: Lung transplant for severe COVID-19  TBA(Toronto General Hospital) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 12:30~12:50 Lung transplant for severe COVID-19 in Korea  Àü°æ¸¸(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø È£Èí±â³»°ú) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 12:50~13:10 Extracorporeal Membrane Oxygenation for COVID-19: Technical aspects and outcomes  Á¤Àμ®(Àü³²ÀÇ´ë Àü³²´ëº´¿ø ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 13:10~13:30 Extracorporeal membrane oxygenation support in COVID-19: Current status of national cohort studies  ¼Õ±¹Èñ(°¡ÃµÀÇ´ë ±æº´¿ø ÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 13:30~13:50 Extracorporeal membrane oxygenation support in COVID-19: SNUH experience  ¹Ú»ùÀ̳ª(¼­¿ïÀÇ´ë ¼­¿ï´ëº´¿ø ÈäºÎ¿Ü°ú) 
Åä·Ð 12-11 ±×·£µåº¼·ë1 13:50~14:00 Discussion  chair 1.¹éȿä 2.ÃÖ¿ë¼ö(1.¿¬¼¼ÀÇ´ë ½ÅÃ̼¼ºê¶õ½ºº´¿ø ÈäºÎ¿Ü°ú 2.¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø ÈäºÎ¿Ü°ú) 
È޽Ġ12-11 ±×·£µåº¼·ë1 14:00~14:10 È޽Ġ () 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 14:10~14:30 Genetic susceptibility to severe COVID-19  ¹ÚÁö¸í(¼­¿ïÀÇ´ë ¼­¿ï´ëº´¿ø È£Èí±â³»°ú) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 14:30~14:50 Studying COVID-19 with lung organoids  ÁÖ¿µ¼®(Ä«À̽ºÆ®) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 14:50~15:10 Vaccination for COVID-19  °­Ã¢°æ(¼­¿ïÀÇ´ë ¼­¿ï´ëº´¿ø °¨¿°³»°ú) 
±³À°½Ã°£ 12-11 ±×·£µåº¼·ë1 15:10~15:30 Thoracic surgery after the COVID-19 pandemic  ³ª±ÇÁß(¼­¿ïÀÇ´ë ¼­¿ï´ëº´¿ø ÈäºÎ¿Ü°ú) 
Åä·Ð 12-11 ±×·£µåº¼·ë1 15:30~15:40 Discussion  chair 1.±èµ¿°ü 2.ÀÌÈ£¼®(1.¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø ÈäºÎ¿Ü°ú 2.ºÎ»êÀÇ´ë ºÎ»ê´ëº´¿ø ÈäºÎ¿Ü°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼­¿ï´ëÇб³º´¿ø SNUH Update symposium : 2021-12-11""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ºÎ»ê±¤¿ª½ÃÀÇ»çȸ Á¦3±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤ : 2021-12-11
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇÑ°ø°øÀÇÇÐȸ Ãß°èÇмú´ëȸ : 2021-12-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20790 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦52Â÷ ÀÎõºÎõÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-15 0 2 2024-05-27
20789 ¼­¿ï 2024³â ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°­Á : 2024-06-15 0 5 2024-05-27
20788 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-15 0 3 2024-05-27
20787 Ãæ³² (¿Â¶óÀÎ)2024³âµµ Ãæû³²µµÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 4 2024-05-27
20786 ºÎ»ê KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14 0 3 2024-05-27
20785 ¼­¿ï 2024³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (´Ù½Ã, °Ü¿ï³ª¹«¿¡¼­ º½ ³ª¹«¿¡·Î From Traditional approaches to Innovation in Psychiatry) : 2024-06-14 0 6 2024-05-27
20784 ¼­¿ï ´ëÇÑ°áÇÙÇùȸ 2024³â °áÇÙ°ü¸®±³À° 1±â(2ÀÏÂ÷) : 2024-06-14 0 3 2024-05-27
20783 ¼­¿ï Á¦14Â÷ Çѱ¹ÃÖ¼Òħ½ÀÃéÀå¼ö¼ú¿¬±¸È¸ : 2024-06-14 0 1 2024-05-27
20782 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç (2ÀÏÂ÷) : 2024-06-14 0 3 2024-05-27
20781 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø RARE DISEASE SYMPOSIUM 2024 : 2024-06-14 0 1 2024-05-27
20780 ºÎ»ê 2024 ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦2Â÷ Á¤±âÇмú´ëȸ : 2024-06-14 0 3 2024-05-27
20779 ¼­¿ï 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14 0 4 2024-05-27
20778 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 6 2024-05-27
20777 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14 0 4 2024-05-27
20776 ºÎ»ê 2024³â Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ºÎ¿ï°æÁöȸ °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-14 0 4 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷